NCT04617626View on ClinicalTrials.gov

Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire

NACompletedINTERVENTIONAL
Enrollment

1,735

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Child MortalityAzithromycin
Interventions
DRUG

Azithromycin

Single dose of azithromycin suspension

Trial Locations (1)

Unknown

Boundiali Health District, Boundiali

All Listed Sponsors
collaborator

National Program for the Fight Against Neglected Tropical Diseases, Côte d'Ivoire

UNKNOWN

lead

FHI 360

OTHER

NCT04617626 - Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire | Biotech Hunter | Biotech Hunter